Mucin expression in gastric cancer: Reappraisal of its clinicopathologic and prognostic significance

Archives of Pathology and Laboratory Medicine

Volumn 137, Issue 8, 2013, Pages 1047-1053

  Kim, Dae Hwan ^a   Shin, Nari ^b   Kim, Gwang Ha ^c   Song, Geum Am ^c   Jeon, Tae Yong ^a   Kim, Dong Heon ^a   Lauwers, Gregory Y ^d   Park, Do Youn ^b  

^a Department of Surgery ^*  (South Korea)

^b Pusan National University Hospital   (South Korea)

^c Pusan National University School of Medicine   (South Korea)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE METALLOENDOPEPTIDASE; MUC2 PROTEIN, HUMAN; MUC5AC PROTEIN, HUMAN; MUC6 PROTEIN, HUMAN; MUCIN; MUCIN 2; MUCIN 5AC; MUCIN 6;

AGED; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; STOMACH TUMOR;

AGED; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MUCIN 5AC; MUCIN-2; MUCIN-6; MUCINS; NEPRILYSIN; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 84881079716     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2012-0193-OA     Document Type: Article

References (24)

1. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31-49.
2. Nakamura K, Sugano H, Takagi K. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gann. 1968;59(3):251-258.
3. Tatematsu M, Tsukamoto T, Inada K. Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci 2003;94(2): 135-141.
4. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer. 2004;4(1):45-60.
5. Toki F, Takahashi A, Aihara R, et al. Relationship between clinicopathological features and mucin phenotypes of advanced gastric adenocarcinoma. World J Gastroenterol. 2010;16(22):2764-2770.
6. Lee OJ, Kim HJ, Kim JR, Watanabe H. The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications. Oncol Rep. 2009;21(2):387-393.
7. Wakatsuki K, Yamada Y, Narikiyo M, et al. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer. J Surg Oncol. 2008; 98(2):124-129.
8. Lee WA, Shu IS, Li YH, Eum JH, Yu WS, Bae HI. Genetic expression pattern of gastric carcinomas according to cellular mucin phenotypes. Korean J Pathol. 2007;41(5):307-315.
9. Kocer B, Soran A, Kiyak G, et al. Prognostic significance of mucin expression in gastric carcinoma. Dig Dis Sci. 2004;49(6):9549-9564.
10. Wang JY, Chang CT, Hsieh JS, et al. Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas. J Surg Oncol. 2003; 83(4):253-260.
11. Lee HS, Lee HK, Kim HS, Yang HK, Kim YI, Kim WH. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer. 2001;92(6):1427-1434.
12. Pinto-de-Sousa J, David L, Reis CA, Gomes R, Silva L, Pimenta A. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma. Virchows Arch. 2002;440(3):304-310.
13. Tajima Y, Shimoda T, Nakanishi Y, et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology. 2001;61(3):212-220.
14. Kim WH, Park CK, Kim YB, et al. A standardized pathology report for gastric cancer. Korean J Pathol. 2005;39(2):106-113.
15. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14(2):101-112.
16. Washington MK. Stomach. In: Edge SB, Byrd DR, eds. American Joint Committee on Cancer Staging Manual. 7th ed. New York, NY: Springer; 2009: 117-121.
17. Tsukashita S, Kushima R, Bamba M, Sugihara H, Hattori T. MUC gene expression and histogenesis of adenocarcinoma of the stomach. Int J Cancer. 2001;94(2):166-170.
18. Tatematsu M, Furihata C, Katsuyama T, et al. Gastric and intestinal phenotypic expressions of human signet ring cell carcinomas revealed by their biochemistry, mucin histochemistry, and ultrastructure. Cancer Res. 1986;46(9): 4866-4872.
19. Bamba M, Sugihara H, Kushima R, et al. Time-dependent expression of intestinal phenotype in signet ring cell carcinomas of the human stomach. Virchows Arch. 2001; 438(1): 49-56.
20. Yoshikawa A, Inadaki K, Yamachika T, Shimizu N, Kaminishi M, Tatematsu M. Phenotypic shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression. Gastric Cancer. 1998; 1(2):134-141.
21. Saito A, Shimoda T, Nakanishi Y, Ochiai A, Toda G. Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. Pathol Int. 2001;51(3):165-171.
22. Koseki K, Takizawa T, Koike M, Ito M, Nihei Z, Sugihara K. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer. 2000; 89(4): 724-732.
23. Lee SH, Kang HJ, Shin DH, et al. Expression of beta-catenin and its mechanism of delocalization in intestinal-type early gastric cancer based on mucin expression. Histol Histopathol. 2009;24(7):831-838.
24. Shin N, Kim HY, Kim WK, et al. Molecular biological characteristics of differentiated early gastric cancer on the basis of mucin expression. Korean J Pathol. 2011;45(1):69-78.